Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Table of Contents:; Normal hematopoiesis / Kyle Greene and Tsewang Tashi -- Red blood cell production disorders / Jessica Thibault and Josef T. Prchal -- Red cell destruction disorders / Sabarinath Venniyil Radhakrishnan and Charles J. Parker -- The sickle cell syndromes / Sarah Yentz and Albert Qu…
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency PG Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr Missing | Available | ||
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available |
c.1 BC Cancer Agency VAN Library | On Loan, due Monday, June 10, 2024 | ||
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency PG Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency SUR Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr Missing | Available |
Table of contents:; Introduction to peripheral blood film examination -- Hematopoiesis -- Erythrocyte maturation -- Megakaryocyte maturation -- Neutrophil maturation -- Monocyte maturation -- Eosinophil maturation -- Basophil maturation -- Lymphocyte maturation -- Variations in size and color of er…
Contents:; Normal Hematopoiesis -- Neutrophil Disorders -- Other Myeloid Disorders -- Bone Marrow Failure Disorders -- Myeloproliferative Disorders -- Hypoproliferative Anemia -- Hemolytic Anemia -- Sickle Cell Disease and Other Hemoglobinopathies -- Iron Metabolism and Porphyria -- Platelet Disord…
c.1 BC Cancer Agency VAN Library | Available |
Contents:; Iron deficiency -- Deficiencies of vitamin band folate -- Hemolytic anemia -- Sickle cell anemia and thalassemia -- Porphyrias -- Bone marrow failure syndromes: aplastic anemia, acquired and constitutional; paroxysmal nocturnal hemoglobinuria; pure red blood cell aplasia; and agranulocyt…
c.1 BC Cancer Agency KEL Library | Available |
Table of Contents:; 1 THORACIC CANCERS -- 2 DIGESTIVE SYSTEM CANCERS -- 3 HEAD AND NECK -- 4 URINARY SYSTEM -- 5 FEMALE REPRODUCTIVE CANCER -- 6 MALE REPRODUCTIVE CANCERS -- 7 BREAST CANCER -- 8 HEMATOLOGIC CANCERS -- 9 SKIN CANCER -- 10 ENDOCRINE CANCERS -- 11 CANCER OF THE NERVOUS SYSTEM AND EYE …
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency PG Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available |
c.3 BC Cancer Agency VAN Library | On Loan, due Friday, December 20, 2019 | ||
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency PG Cancer Info Ctr Missing | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.3 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency VIC Cancer Info Ctr | Available |
"Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia…
"This book presents the clinical scope of cancer immunotherapeutic agents for solid tumors and Hematologic malignancies, elaborates on the scientific details of their modes of action, and presents the impact of these agents on oncology, patients and the broader healthcare system. At present, cancer…
Contents:; Biologics and the need for biosimilars -- Why do we need biosimilars? -- How is the quality of biosimilar medicines assured? -- Legal issues -- Switching, interchangeability and extrapolation -- Safety and pharmacovigilant -- Global issues -- Formulary considerations: pharmacy issues -- …
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.3 BC Cancer Agency VIC Cancer Info Ctr | Available |
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.3 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |